Evidence map›Paper›PMID 41426914›Full record

ArticleCureus2025

Detection and Epidemiological Characterization of Respiratory Pathogens Causing Infections in Patients at Hospital Angeles Lindavista.

Mauricio Castillo-Salazar, Valentina Flores-Gallardo, María Fernanda Villavicencio-Pérez, José Luis Pinacho-Velázquez, Carlos Andrey Diosdado-Franco, Luis Gerardo Balcázar-Ochoa, Laura Gómez-Virgilio

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mauricio Castillo-SalazarLaboratory and Blood Bank, Hospital Angeles Lindavista, Mexico City, MEX.
Valentina Flores-GallardoMedical Education, Hospital Angeles Lindavista, Mexico City, MEX.
María Fernanda Villavicencio-PérezMedical Education, Hospital Angeles Lindavista, Mexico City, MEX.
José Luis Pinacho-VelázquezPediatrics, Hospital Angeles Lindavista, Mexico City, MEX.
Carlos Andrey Diosdado-FrancoGeneral Management, Hospital Angeles Lindavista, Mexico City, MEX.
Luis Gerardo Balcázar-OchoaMedical Education, Hospital Angeles Lindavista, Mexico City, MEX.
Laura Gómez-VirgilioMedical Education, Hospital Angeles Lindavista, Mexico City, MEX.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimRespiratory infections are a major cause of morbidity, particularly among young children and older adults. This study aimed to characterize respiratory pathogens detected at Hospital Angeles Lindavista and identify demographic and clinical factors associated with infection patterns.

methodsThis retrospective study analyzed the distribution of respiratory pathogens in patients seen between 2022 and 2024 at a private tertiary hospital using the FilmArray (Lyon, France: bioMérieux) molecular diagnostic panel. We reviewed variables such as demographic data, patient type, comorbidities, risk factors, diagnosis, detected pathogens, and type of infection. We conducted an exploratory analysis using chi-square tests to identify statistically significant associations between our variables (p<0.05). Multinomial regression models were used to characterize these associations.

resultsThe dataset included 718 patients, with simple infections being the most common, accounting for 400 (55.6%) cases. The most prevalent pathogens were human rhinovirus/enterovirus (n=117), influenza (n=67), and respiratory syncytial virus (RSV) (n=67). Multivariate regression analysis identified pediatric age as the most significant risk factor for coinfection; children under five years had higher odds of a double infection compared to adults (OR=83.89, 95% CI: 6.38-27531.38, p<0.001). Specific pathogens were strongly age-associated, with RSV and rhinovirus/enterovirus predominating in children, while SARS-CoV-2 was significantly less common in pediatric groups. Notably, a diagnosis of COVID-19 or influenza was negatively associated with the presence of rhinovirus/enterovirus. After model penalization, no statistically significant seasonal pattern was observed.

conclusionThese findings underscore the importance of age as a major risk factor for respiratory tract infections in general, and for specific etiological agents, such as respiratory syncytial virus, which has particular significance in pediatric populations due to its potential clinical severity and sequelae. These results also highlight the relevance of other microbes, such as human rhinovirus/enterovirus, as a common cause of respiratory tract infections, and previous infections as a risk factor. Finally, this study also emphasizes the potential of molecular diagnostics as a clinical tool and a resource for surveillance, treatment guidance, and preventive strategies.

Indexed as

coinfectionsepidemiological characterizationmedical comorbiditiesrespiratory molecular panelrespiratory tract pathogensrisk factors

Identifiers

PMID41426914
PMCPMC12715028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.